Shopping Cart
Remove All
Your shopping cart is currently empty
UNC9750 is an inhibitor of inositol phosphate multikinase (IPMK), with IC50 values of 31.6 nM for IPMK and 374 nM for IP6K2. It effectively suppresses the accumulation of InsP5, a direct product of IPMK kinase activity, without affecting InsP6 or InsP7 levels. Additionally, UNC9750 inhibits over 75% of the activity of four kinases: DAPK1, DYRK1B, PDGFR, and KDR. This compound is applicable in glioblastoma research.


| Description | UNC9750 is an inhibitor of inositol phosphate multikinase (IPMK), with IC50 values of 31.6 nM for IPMK and 374 nM for IP6K2. It effectively suppresses the accumulation of InsP5, a direct product of IPMK kinase activity, without affecting InsP6 or InsP7 levels. Additionally, UNC9750 inhibits over 75% of the activity of four kinases: DAPK1, DYRK1B, PDGFR, and KDR. This compound is applicable in glioblastoma research. |
| In vitro | UNC9750 (Compound 14), at concentrations ranging from 0-10 μM over 48-72 hours, inhibits the growth of U251-MG human glioblastoma cells and selectively reduces intracellular InsP 5 levels without affecting those of InsP 6 or InsP 7. At 1 μM, UNC9750 inhibits four kinases (DAPK1, DYRK1B, PDGFR, and KDR) with an inhibition rate of 75% or more. Furthermore, UNC9750 at concentrations between 10-50 μM over 24 hours significantly and dose-dependently upregulates the expression of the SF-1 target gene CYP11A1. |
| Molecular Weight | 400.48 |
| Formula | C23H24N6O |
| Cas No. | 2967648-29-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.